Generics Maker Settles Imitrex Suit With Glaxo
Cobalt Laboratories Inc. has become the third generics maker in the past five weeks to settle litigation with GlaxoSmithKline over the patent for the migraine treatment Imitrex....To view the full article, register now.
Already a subscriber? Click here to view full article